13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 53 holding rows worth $116,785,040.
- Accession
- 0001420506-24-000954
- Filer
- CIK 2011932
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 53 entries on the cover page, a total value of $116,785,040 stated on the cover page (in dollars after the unit check, H1), rows summing to $116,785,040 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 9,700 | $7,546,212 | dollars as filed | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 86,000 | $6,308,100 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 36,800 | $5,755,152 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 15,300 | $5,556,807 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 117,000 | $4,637,880 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 230,300 | $3,502,863 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 135,169 | $3,449,513 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 87,846 | $3,447,077 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 24,828 | $3,443,644 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 274,900 | $3,106,370 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 71,100 | $2,984,067 | dollars as filed | |
| GERON CORP | 374163103 | COM | 886,800 | $2,926,440 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 98,485 | $2,912,201 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 154,800 | $2,808,072 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 362,487 | $2,794,775 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 14,700 | $2,615,571 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 6,358 | $2,537,414 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 66,300 | $2,410,005 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 7,900 | $2,109,616 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 273,413 | $2,094,344 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 45,603 | $1,975,978 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 71,700 | $1,945,221 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 369,322 | $1,894,622 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 26,700 | $1,843,902 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 26,008 | $1,823,421 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 84,470 | $1,779,783 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 8,200 | $1,768,166 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 193,600 | $1,761,760 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 59,902 | $1,751,534 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 18,650 | $1,705,729 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 7,353 | $1,641,043 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 79,000 | $1,629,770 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 143,400 | $1,623,288 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 55,700 | $1,593,020 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 48,807 | $1,509,112 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 227,821 | $1,494,506 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 163,100 | $1,474,424 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 30,100 | $1,444,198 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 59,650 | $1,405,354 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 20,300 | $1,404,760 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 4,000 | $1,302,520 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 415,434 | $1,275,382 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 402,504 | $1,159,212 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 65,021 | $1,107,958 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 65,300 | $1,046,106 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 57,635 | $1,013,800 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 163,922 | $901,571 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 17,800 | $831,082 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 325,762 | $605,917 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 155,383 | $435,072 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 60,900 | $330,078 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 75,300 | $282,375 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 61,135 | $78,253 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000954 | this filing | 2024-05-15 | acceptance time not in the bulk data set |